| Design and baseline characteristics of the stroke prevention by aggressive reduction in cholesterol levels (SPARCL) study GE Carlsson, A Möller, C Blomstrand, T Ueda, K Mizushige, K Yukiiri, ... Cerebrovascular Diseases 16 (4), 389-395, 2003 | 289 | 2003 |
| Aspirin-insensitive thromboxane biosynthesis in essential thrombocythemia is explained by accelerated renewal of the drug target S Pascale, G Petrucci, A Dragani, A Habib, F Zaccardi, F Pagliaccia, ... Blood, The Journal of the American Society of Hematology 119 (15), 3595-3603, 2012 | 243 | 2012 |
| Effects of secondary prophylaxis started in adolescent and adult haemophiliacs A Tagliaferri, M Franchini, A Coppola, GF Rivolta, C Santoro, G Rossetti, ... Haemophilia 14 (5), 945-951, 2008 | 159 | 2008 |
| The contribution of cyclooxygenase-1 and-2 to persistent thromboxane biosynthesis in aspirin-treated essential thrombocythemia: implications for antiplatelet therapy A Dragani, S Pascale, A Recchiuti, D Mattoscio, S Lattanzio, G Petrucci, ... Blood, The Journal of the American Society of Hematology 115 (5), 1054-1061, 2010 | 123 | 2010 |
| European stroke initiative recommendations for stroke management–update 2003 GE Carlsson, A Möller, C Blomstrand, T Ueda, K Mizushige, K Yukiiri, ... Cerebrovascular Diseases 16 (4), 311-337, 2003 | 119 | 2003 |
| Clinical and laboratory features of 103 patients from 42 Italian families with inherited thrombocytopenia derived from the monoallelic Ala156Val mutation of GPIbα (Bolzano … P Noris, S Perrotta, R Bottega, A Pecci, F Melazzini, E Civaschi, S Russo, ... haematologica 97 (1), 82, 2012 | 107 | 2012 |
| A randomized double-blind trial of 3 aspirin regimens to optimize antiplatelet therapy in essential thrombocythemia B Rocca, A Tosetto, S Betti, D Soldati, G Petrucci, E Rossi, A Timillero, ... Blood, The Journal of the American Society of Hematology 136 (2), 171-182, 2020 | 83 | 2020 |
| Differences between patients’, physicians’ and pharmacists’ preferences for treatment products in haemophilia: a discrete choice experiment LG Mantovani, MS Monzini, PM Mannucci, L Scalone, M Villa, A Gringeri, ... Haemophilia 11 (6), 589-597, 2005 | 68 | 2005 |
| Qualitative and quantitative modifications of von Willebrand factor in patients with essential thrombocythemia and controlled platelet count S Lancellotti, A Dragani, P Ranalli, G Petrucci, M Basso, R Tartaglione, ... Journal of Thrombosis and Haemostasis 13 (7), 1226-1237, 2015 | 66 | 2015 |
| Homocysteine modulates the CD40/CD40L system C Prontera, N Martelli, V Evangelista, E D’Urbano, S Manarini, ... Journal of the American college of Cardiology 49 (22), 2182-2190, 2007 | 59 | 2007 |
| Long-term death and recurrence in patients with acute venous thromboembolism: the MASTER registry M Verso, G Agnelli, W Ageno, D Imberti, M Moia, G Palareti, R Pistelli, ... Thrombosis research 130 (3), 369-373, 2012 | 57 | 2012 |
| A multicentre observational study for early diagnosis of Gaucher disease in patients with Splenomegaly and/or Thrombocytopenia I Motta, M Filocamo, E Poggiali, M Stroppiano, A Dragani, D Consonni, ... European journal of haematology 96 (4), 352-359, 2016 | 47 | 2016 |
| Circulating endothelial progenitor cells and residual in vivo thromboxane biosynthesis in low-dose aspirin-treated polycythemia vera patients F Santilli, M Romano, A Recchiuti, A Dragani, A Falco, G Lessiani, ... Blood, The Journal of the American Society of Hematology 112 (4), 1085-1090, 2008 | 47 | 2008 |
| Evaluation of four different methods for platelet freezing G Torlontano, A Angelini, A Dragani, A Berardi, A Iacone, G Fioritoni Vox sanguinis 62 (3), 146-151, 1992 | 46 | 1992 |
| Chromosome changes in 19 patients with Waldenström's macroglobulinemia G Palka, A Spadano, L Geraci, G Fioritoni, A Dragani, G Calabrese, ... Cancer genetics and cytogenetics 29 (2), 261-269, 1987 | 43 | 1987 |
| Is the absence of JAK2V617F mutation a risk factor for bleeding in essential thrombocythemia? An analysis of 106 patients A Patriarca, F Pompetti, R Malizia, O Iuliani, I Di Marzio, A Spadano, ... Blood Transfusion 8 (1), 21, 2010 | 40 | 2010 |
| The Aspirin Regimens in Essential Thrombocythemia (ARES) phase II randomized trial design: Implementation of the serum thromboxane B2 assay as an … V De Stefano, B Rocca, A Tosetto, D Soldati, G Petrucci, E Beggiato, ... Blood Cancer Journal 8 (6), 49, 2018 | 36 | 2018 |
| Identifying determinants of variability to tailor aspirin therapy B Rocca, A Dragani, F Pagliaccia Expert review of cardiovascular therapy 11 (3), 365-379, 2013 | 36 | 2013 |
| Efficacy and safety during formulation switch of a pasteurized VWF/FVIII concentrate: results from an Italian prospective observational study in patients with von Willebrand … G Castaman, A Coppola, E Zanon, E Boeri, M Musso, S Siragusa, ... Haemophilia 19 (1), 82-88, 2013 | 35 | 2013 |
| Oxidative stress and platelet activation in subjects with moderate hyperhomocysteinaemia due to MTHFR 677 C→ T polymorphism A Dragani, A Falco, F Santilli, S Basili, G Rolandi, L Cerasa, S Lattanzio, ... Thrombosis and haemostasis 108 (09), 533-542, 2012 | 29 | 2012 |
Giovanni DavìProfessor of Internal Medicine, University of Chieti, ItalyVerified email at unich.it
